Follow-The-Filings

Security · featured owners

TYRA Tyra Biosciences Inc.

Health Care COM Equity as of 2026 Q2 among managers we track

  • 1 exit

TYRA (Tyra Biosciences Inc.) 13F ownership among featured managers we track as of 2026 Q2. Figures are as-filed 13F, not free float.

Holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

History
Farallon Capital Management exited 2026 Q2 Last 2026 Q1 0.78% Exit −0.78% 3,580,818 $137M History

0 current · 1 exited last period · options excluded

SEC filings

Recent issuer filings from EDGAR · 15 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
424B5 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 8.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
424B5 Filing Doc
8-K 5.07 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 5.02 Filing Doc
DEFA14A Filing Doc
8-K 5.02 Filing Doc
8-K 8.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-K Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 11 rows shown

Filed Form Detail Links
4 Period Sep 15, 2026 · 4 forms Filing Doc
4 Period Sep 9, 2026 Filing Doc
4 Period May 28, 2026 · 7 forms Filing Doc
4 Period May 5, 2026 · 5 forms Filing Doc
4 Period Apr 16, 2026 Filing Doc
4 Period Mar 25, 2026 Filing Doc
4 Period Mar 13, 2026 · 2 forms Filing Doc
4 Period Feb 12, 2026 Filing Doc
4 Period Jan 12, 2026 Filing Doc
4 Period Dec 19, 2025 Filing Doc
4 Period Dec 12, 2025 Filing Doc

Updated 12 days ago Source: SEC EDGAR submissions All on EDGAR

Financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Net income -$69.13M -$86.48M -$119.95M

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $211.67M $347.46M $265.45M
Total non-current assets * $14.19M $16.1M $17.16M
Total assets $225.86M $363.56M $282.61M
Total current liabilities $15.33M $14.59M $18.09M
Total non-current liabilities * $6.26M $5.81M $5.34M
Total equity $204.26M $343.15M $259.18M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$50.14M -$69.77M -$95.14M
Cash from investing -$144.6M -$98.4M $72.46M
Cash from financing $1.54M $202.14M $8.1M
Net change in cash -$193.21M $33.96M -$14.58M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

Ownership over time

filing count by report period · click a bar for that quarter’s holders